Free Trial

Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Boston Partners

Molina Healthcare logo with Medical background
Remove Ads

Boston Partners lowered its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 25.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 955,170 shares of the company's stock after selling 327,798 shares during the quarter. Boston Partners owned approximately 1.67% of Molina Healthcare worth $278,029,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in MOH. Public Sector Pension Investment Board lifted its position in shares of Molina Healthcare by 13.5% during the 3rd quarter. Public Sector Pension Investment Board now owns 2,527 shares of the company's stock worth $871,000 after purchasing an additional 300 shares during the last quarter. Tributary Capital Management LLC lifted its holdings in Molina Healthcare by 76.1% during the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock worth $1,219,000 after buying an additional 1,811 shares during the last quarter. Everence Capital Management Inc. purchased a new stake in Molina Healthcare during the 4th quarter worth about $544,000. Smartleaf Asset Management LLC lifted its stake in Molina Healthcare by 123.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after purchasing an additional 192 shares during the last quarter. Finally, SYM FINANCIAL Corp purchased a new stake in Molina Healthcare during the fourth quarter worth approximately $249,000. Hedge funds and other institutional investors own 98.50% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on MOH. JPMorgan Chase & Co. restated a "neutral" rating and set a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Barclays reduced their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research report on Friday, February 7th. Mizuho reduced their price target on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. UBS Group reduced their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Finally, Truist Financial reduced their target price on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $355.69.

Remove Ads

Check Out Our Latest Analysis on MOH

Insider Activity at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.10% of the company's stock.

Molina Healthcare Trading Down 1.7 %

Shares of Molina Healthcare stock traded down $5.42 during trading hours on Friday, reaching $309.85. The stock had a trading volume of 1,046,887 shares, compared to its average volume of 613,436. The firm has a 50 day simple moving average of $299.99 and a two-hundred day simple moving average of $309.37. The firm has a market capitalization of $16.95 billion, a price-to-earnings ratio of 15.17, a P/E/G ratio of 1.06 and a beta of 0.56. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads